Vitamin K Supplementation for Reducing Cardiovascular Events in End-Stage Chronic Kidney Disease: A Systematic Review
Keywords:
Vitamin K Supplementation, Cardiovascular, End-stage Chronic Kidney DiseaseAbstract
This study was conducted to analyze the hSIL of Vitamin K Supplementation in Reducing Cardiovascular Events in End-Stage Chronic Kidney Disease: A Systematic Review. Cardiovascular disease (CVD) is the leading source of morbidity and mortality worldwide, and chronic kidney disease (CKD) is a major contributor to this matter. Kidney disease is estimated to affect over 850 million people worldwide. The present systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. We searched studies from electronic databases (PubMed Central, ScienceDirect, PLoS One, Google Scholar, Nature). Studies were considered eligible if they met the following criteria : (1) the study is a randomized controlled trial (RCT), (2) the study was published in the last 5 years (2018– 2022), (3) the study participants were adult patients with kidney disease from stage III to end-stage who were given vitamin K supplementation, (4) the study reported coronary artery calcium scores pre- and post- vitamin K supplementation, (5) the study was published in English. Risk of bias of each study was evaluated using Cochrane Risk of Bias (RoB) 2 tool. Data were descriptively examined and narratively reported. In conclusion, our results do not suggest that vitamin K supplementation may affect vascular calcification as measured by the CAC score. Up till now there is no treatment to reverse vascular calcification in ESKD patients. The current clinical practice should focus on prevention and retardation of its progression.
Downloads
References
L. M. Freeman en J. E. Rush, “Nutritional management of cardiovascular diseases”, Appl. Vet. Clin. Nutr., bll 461–483, 2023.
C. M. de Carvalho, L. A. Gross, M. J. de Azevedo, en L. V. Viana, “Dietary Fiber Intake (Supplemental or Dietary Pattern Rich in Fiber) and Diabetic Kidney Disease: A Systematic Review of Clinical Trials”, Nutrients, vol 11, no 2, bl 347, Feb 2019, doi: 10.3390/nu11020347.
S. Czaja-Stolc, M. Potrykus, M. Stankiewicz, Ł. Kaska, en S. Małgorzewicz, “Pro-inflammatory profile of adipokines in obesity contributes to pathogenesis, nutritional disorders, and cardiovascular risk in chronic kidney disease”, Nutrients, vol 14, no 7, bl 1457, 2022.
S. Czaja-Stolc, M. Potrykus, M. Stankiewicz, Ł. Kaska, en S. Małgorzewicz, “Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease”, Nutrients, vol 14, no 7, bl 1457, Mrt 2022, doi: 10.3390/nu14071457.
H. Zhang et al., “Alternate-day fasting alleviates diabetes-induced glycolipid metabolism disorders: roles of FGF21 and bile acids”, J. Nutr. Biochem., vol 83, bl 108403, Sep 2020, doi: 10.1016/j.jnutbio.2020.108403.
C. Zoccali et al., “Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association”, Cardiovasc. Res., vol 119, no 11, bll 2017–2032, 2023.
S. Roumeliotis, V. Liakopoulos, en L. J. Schurgers, “Vitamin K Supplementation in Chronic Kidney Disease Patients: Where is the Evidence?”, Curr. Vasc. Pharmacol., vol 20, no 2, bll 121–126, Mrt 2022, doi: 10.2174/1570161120666220209145341.
Y. Ikari et al., “Switching from Warfarin to rivaroxaban induces sufficiency of vitamin K and reduction of arterial stiffness in patients with atrial fibrillation”, Heart Vessels, vol 35, bll 1727–1733, 2020.
K. Levy-Schousboe et al., “Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial”, Clin. Kidney J., vol 14, no 9, bll 2114–2123, Aug 2021, doi: 10.1093/ckj/sfab017.
M. P. Moore, R. P. Cunningham, R. J. Dashek, J. M. Mucinski, en R. S. Rector, “A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD”, Obesity, vol 28, no 10, bll 1843–1852, Okt 2020, doi: 10.1002/oby.22964.
J. S. Lees et al., “The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients”, Am. J. Transplant., vol 21, no 10, bll 3356–3368, Okt 2021, doi: 10.1111/ajt.16566.
M. F. Ibrahim Mosa en A. K. Harfoosh, “Role Of Vitamin K Therapy In Prevention Of Vascular Calcification In Chronic Kidney Disease”, Eur. J. Med. Heal. Sci., vol 2, no 4, Jul 2020, doi: 10.24018/ejmed.2020.2.4.360.
Z. N. Memel, J. Wang, en K. E. Corey, “Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?”, Clin. Liver Dis., vol 19, no 3, bll 101–105, Mrt 2022, doi: 10.1002/cld.1172.
M. Karyanta, S. Satrowiyoto, en D. P. Wulandari, “Prevalence Ratio of Otitis Media with Effusion in Laryngopharyngeal Reflux”, Int. J. Otolaryngol., vol 2019, bll 1–3, Jan 2019, doi: 10.1155/2019/7460891.
N. Kaesler, L. J. Schurgers, en J. Floege, “Vitamin K and cardiovascular complications in chronic kidney disease patients”, Kidney Int., vol 100, no 5, bll 1023–1036, Nov 2021, doi: 10.1016/j.kint.2021.06.037.
S. D. Emmett, J. Kokesh, en D. Kaylie, “Chronic Ear Disease”, Med. Clin. North Am., vol 102, no 6, bll 1063–1079, Nov 2018, doi: 10.1016/j.mcna.2018.06.008.
N. Salihefendic, M. Zildzic, en E. Cabric, “Laryngopharyngeal Reflux Disease - LPRD”, Med. Arch., vol 71, no 3, bl 215, 2017, doi: 10.5455/medarh.2017.71.215-218.
E. Hariri et al., “Vitamin K 2 —a neglected player in cardiovascular health: a narrative review”, Open Hear., vol 8, no 2, bl e001715, Nov 2021, doi: 10.1136/openhrt-2021-001715.
P. Grzejszczak en I. Kurnatowska, “Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?”, Kidney Blood Press. Res., vol 46, no 5, bll 523–530, 2021, doi: 10.1159/000516611.
R. D. Restuti, S. Tamin, D. A. Nugroho, S. M. Hutauruk, en M. Mansyur, “Factors affecting the occurrence of otitis media with effusion in preschool and elementary school children: a comparative cross-sectional study”, BMJ Open, vol 12, no 9, bl e065291, Sep 2022, doi: 10.1136/bmjopen-2022-065291.
C. Li et al., “Increased risks of different grades of non‐alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7–6.4% in a Chinese population”, J. Diabetes Investig., vol 11, no 5, bll 1336–1343, 2020.
C. Geng, L. Huang, L. Pu, en Y. Feng, “Effects of vitamin K supplementation on vascular calcification in chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials”, Front. Nutr., vol 9, bl 1001826, Jan 2023, doi: 10.3389/fnut.2022.1001826.
N. Boronat-Echeverría et al., “Helicobacter pylori detection and clinical symptomatology of gastroesophageal reflux disease in pediatric patients with otitis media with effusion”, Int. J. Pediatr. Otorhinolaryngol., vol 87, bll 126–129, Aug 2016, doi: 10.1016/j.ijporl.2016.06.023.
L. Dai, L. J. Schurgers, P. G. Shiels, en P. Stenvinkel, “Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage”, Nephrol. Dial. Transplant., vol 35, no Supplement_2, bll ii31–ii37, Mrt 2020, doi: 10.1093/ndt/gfaa006.
J. H. Yoo et al., “Mean and visit‐to‐visit variability of glycated hemoglobin, and the risk of non‐alcoholic fatty liver disease”, J. Diabetes Investig., vol 12, no 7, bll 1252–1262, 2021.
H. Hidaka et al., “Clinical practice guidelines for the diagnosis and management of otitis media with effusion (OME) in children in Japan – 2022 update”, Auris Nasus Larynx, Des 2022, doi: 10.1016/j.anl.2022.12.004.
L. Dai et al., “Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study”, PLoS One, vol 16, no 2, bl e0247623, Feb 2021, doi: 10.1371/journal.pone.0247623.
J. W. Bellinge et al., “Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study”, J. Am. Heart Assoc., vol 10, no 16, bl e020551, Aug 2021, doi: 10.1161/JAHA.120.020551.
M. Cozzolino et al., “Current Therapy in CKD Patients Can Affect Vitamin K Status”, Nutrients, vol 12, no 6, bl 1609, Mei 2020, doi: 10.3390/nu12061609.
F. Bellone et al., “Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health”, Int. J. Mol. Sci., vol 23, no 9, bl 5282, Mei 2022, doi: 10.3390/ijms23095282.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Kevin Liora, Putri Dhiya Prameswari Wiyono, Ananda Putra, Devin Alexander, Afif Ramadhan, Anissya Rima Oktavia, Olivia Larissa, Fajar Prianto Nugroho, Teddy Tjahyanto
This work is licensed under a Creative Commons Attribution 4.0 International License.
